PACB - pacb.com Operating income before deduction of amortization
Pacific Biosciences (PACB) minimizes single-product risks through its specialization in DNA sequencing equipment, given the critical importance of these systems for science. The company's absolute operating profit in monetary terms illustrates this trend, where the level of 0.00 represents the current value. Revenues are based on long-term customer lock-in via proprietary cartridges, while profits are generated by B2B deliveries of HiFi systems and the regular sale of reagents to biopharmaceutical behemoths.
PacBio (PACB) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- market capitalization statistics:
- balance sheet equity data:
- business debt structure and liquidity details:
- earnings and multiples data:
PACB - Net Profit|Company Profit Forecast Pacific Biosciences|PACB - P/E Multiple|Projected Price to Earnings Ratio pacb.com|PACB - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation PacBio|PACB - Operating profit EBITDA|Net earnings per share for the last 12 months PacBio|PACB - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months pacb.com|PACB - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Pacific Biosciences
Analysis of all company metrics:Pacific Biosciences
This indicator is indispensable for asset stress testing, as it allows for an assessment of the business's actual ability to generate cash flow before taxes and debt obligations. By analyzing the current EBITDA of Pacific Biosciences (PACB), an investor can see the monetization efficiency of the Revio and Onso systems, where a steadily rising curve confirms high margins on equipment sales and consistent demand for specialized genomic analysis reagents.
Competitors of Pacific Biosciences (PACB)
TEM (Tempus) - Profit before deduction of interest, taxes, depreciation and amortization|Qiagen N.V. - Operating profit EBITDA|Operating income before deduction of amortization ionispharma.com IONS|RGEN: Operating profit EBITDA|Operating profit before deduction of amortization Avidity Biosciences Inc|Operating profit before deduction of amortization CRSP|WGS: Income before deduction of interest, taxes and amortization|Operating profit EBITDA RARE|Profit before payment of interest, taxes and amortization BEAM (beamtx.com)|Operating profit EBITDA SRPT (Sarepta)|Operating income before deduction of amortization Twist Bioscience Inc (TWST)|TXG - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Intellia Corp|Stoke Therapeutics (STOK) - Profit before payment of interest, taxes and amortization|BLFS - Operating income before deduction of amortization|WVE (Wave Life Sciences Ltd.) - Operating profit EBITDA|Operating profit before deduction of amortization Maze Therapeutics, Inc. (MAZE)|Operating profit EBITDA SION|Operating income before deduction of amortization Prime Medicine Bio|Operating profit EBITDA TSHA (Taysha Gene Therapies)|uniqure.com (QURE) - Profit before interest, taxes and amortization|MGTX - Profit before payment of interest, taxes and amortization|RGNX (REGENXBIO Inc) - Operating profit before amortization|SLDB: Operating profit EBITDA|Operating profit before deduction of amortization Ocugen Pharma|BNTC (Benitec Biopharma Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization designtx.com DSGN|Profit before payment of interest, taxes and amortization Rocket Pharmaceuticals, Inc. (RCKT)|Operating income before deduction of amortization 4DMT|Profit before payment of interest, taxes and amortization Lexeo Therapeutics, Inc. LXEO|KRRO (Korro Bio Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|Editas Medicine, Inc. - Operating profit EBITDA|SLN - Operating profit EBITDA|PRQR: Operating profit EBITDA|Operating profit before deduction of amortization Codexis|SGMO (Sangamo) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NAUT|Operating profit EBITDA MGX|precisionbiosciences.com - Operating profit before amortization|Profit before payment of interest, taxes and amortization Generation Bio GBIO|BOLD: Operating profit before amortization|Exicure Corp - Operating profit EBITDA|IMNN - Operating profit EBITDA|phiopharma.com (PHIO) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization MBIO (Mustang Bio)|RNAZ (TransCode Therapeutics Inc.) - Operating profit EBITDA|Operating profit EBITDA Bionano|Operating profit EBITDA APDN|Operating profit before deduction of amortization bluebird bio, Inc BLUE|Operating profit EBITDA IPA (ImmunoPrecise Antibodies Ltd.)|Operating income before deduction of amortization omegatherapeutics.com (OMGA)|Singular Genomics - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization RGLS|SYRS: Operating profit EBITDA|TBIO - Operating income before deduction of amortization|TCON (TRACON Pharmaceuticals) - Operating profit EBITDA|Operating profit before deduction of amortization unitybiotechnology.com (UBX)
